Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BenQ Medical TechnologyROCO:4116 -1.04%81 PB Ratio is 1.51 as of Jul. 18, 2026, which is 10% below its 10-year median of 1.68. GuruFocus rates ROCO:4116 with a GF Score™ of 81/100 and a GF Value™ of NT$62.39 (Significantly Undervalued). The stock has 6 warning signs investors should review. Among 787 Medical Devices & Instruments companies, BenQ Medical Technology ranks better than 63.15% on this metric.
BenQ Medical Technology Corp stock PB Ratio (=1.5) is close to 3-year low of 1.47.
The historical rank and industry rank for BenQ Medical Technology's PB Ratio or its related term are showing as below:
ROCO:4116'
s PB Ratio Range Over the Past 10 Years
Min: 0.97 Med: 1.68 Max: 3.4
Current: 1.51
During the past 13 years, BenQ Medical Technology's highest PB Ratio was 3.40. The lowest was 0.97. And the median was 1.68.
ROCO:4116's PB Ratio is ranked better than 63.15% of 787
companies
in the Medical Devices & Instruments industry
Industry Median: 2.05
vs ROCO:4116: 1.51
During the past 12 months, BenQ Medical Technology's average Book Value Per Share Growth Rate was 0.40% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -8.90% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 0.80% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 1.70% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of BenQ Medical Technology was 19.00% per year. The lowest was -8.90% per year. And the median was 2.40% per year.
Back to Basics: PB Ratio
BenQ Medical Technology (ROCO:4116) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, BenQ Medical Technology's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BenQ Medical Technology PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, BenQ Medical Technology's PB Ratio distribution charts can be found below:
* The bar in red indicates where BenQ Medical Technology's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
BenQ Medical Technology (ROCO:4116) has a PB Ratio of 1.51 as of Jul. 18, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on BenQ Medical Technology and its competitors. This is 10% below median its historical median of 1.68. Over the past decade, BenQ Medical Technology's PB Ratio has ranged from 0.97 to 3.40. According to the industry distribution chart, BenQ Medical Technology ranks #290 out of 787 companies in the Medical Devices & Instruments industry, placing it in the top 36.8%.
Is BenQ Medical Technology's PB Ratio too high?
BenQ Medical Technology's current PB Ratio of 1.51 is 10% below median its 10-year median of 1.68. Over the past 10 years, this metric has ranged from a low of 0.97 to a high of 3.40. The Medical Devices & Instruments industry median PB Ratio is 2.05. BenQ Medical Technology's value of 1.51 is 26.3% below this industry median. Based on the distribution chart, BenQ Medical Technology ranks #290 out of 787 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, BenQ Medical Technology has a GF Score™ of 81/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does BenQ Medical Technology's PB Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, BenQ Medical Technology ranks #290 out of 787 companies for PB Ratio. This puts BenQ Medical Technology in the upper half of its industry. The industry median PB Ratio is 2.05. BenQ Medical Technology's value of 1.51 is 26.3% below this benchmark. Historically, BenQ Medical Technology's own PB Ratio has ranged from 0.97 to 3.40 over the past decade. While the company's 10-year median is 1.68 vs. the industry median of 2.05, BenQ Medical Technology has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.05, based on 787 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BenQ Medical Technology's current PB Ratio of 1.51 is 26.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on BenQ Medical Technology and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BenQ Medical Technology's current PB Ratio is 1.51, which is 10% below median its own 10-year median of 1.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BenQ Medical Technology stock overvalued right now?
Based on GuruFocus' analysis, BenQ Medical Technology (ROCO:4116) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$62.39, compared to a current price of NT$38.20 — trading 38.8% below its estimated fair value. The current PB Ratio is 1.51, which is 10% below median its 10-year median of 1.68 and 26.3% below the Medical Devices & Instruments industry median of 2.05. BenQ Medical Technology's overall GF Score™ is 81/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For BenQ Medical Technology (ROCO:4116), the current PB Ratio is 1.51 as of Jul. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is BenQ Medical Technology (ROCO:4116) Overvalued in 2026?
Based on GuruFocus' analysis, BenQ Medical Technology stock appears to be undervalued.
The current stock price of NT$38.20 is trading 38.8% below its estimated GF Value™ of NT$62.39.
GuruFocus considers BenQ Medical Technology to be Significantly Undervalued.
Key valuation signals for ROCO:4116:
PB Ratio: 1.51 (10% below median its 10-year median of 1.68)
GF Value™: NT$62.39 vs. price of NT$38.20 (38.8% below fair value)
Industry Position: 26.3% below the Medical Devices & Instruments median (#290 of 787)
No single metric tells the full story. See the ROCO:4116 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
BenQ Medical Technology Corp is engaged in the manufacturing, assembly, maintenance, repair, and sales of professional medical equipment and consumables. Its products include surgical and gynecology tables, digital OR solutions, halogen and LED surgical lights, and medical imaging products, among others. The company's segment includes the R&D and Manufacturing Division and the Medical Services Division. The company generates the majority of its revenue from the Medical Services Division. Geographically, the company generates revenue from Taiwan, Mainland China, Indonesia, Thai, India, Colombia, and Others.
81GF Score
Get the complete analysis for ROCO:4116
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4116 has been successfully added to your 
